Details for New Drug Application (NDA): 018342
✉ Email this page to a colleague
The generic ingredient in WELLCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.
Summary for 018342
Tradename: | WELLCOVORIN |
Applicant: | Glaxosmithkline |
Ingredient: | leucovorin calcium |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018342
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 8, 1983 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | EQ 25MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 8, 1983 | TE: | RLD: | Yes |
Complete Access Available with Subscription